title: [Sarcoidosis].
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: F
authors.initials: F
authors.lastname: Huber-Geismann
authors.forename: D
authors.initials: D
authors.lastname: Franzen
authors.forename: E
authors.initials: E
authors.lastname: Russi
mesh_terms: D000328:Adult; D017668:Age of Onset; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001999:Bronchoscopy; D002493:Central Nervous System Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D042241:Early Diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012507:Sarcoidosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D017565:Sarcoidosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D014057:Tomography, X-Ray Computed
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011241:Prednisone